GlassScriptPhysician profile
Angela Snyder
NPI 1114904893
$1,948.44
in general payments reported to CMS, 2019-2025
11 companies · $491 in 2025
The $491 reported for 2025 was more than what 92% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $318 · 2022: $336 · 2023: $368 · 2024: $436 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,294.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Servier Pharmaceuticals LLC | $393.20 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $235.30 | 2024-2025 | |
| Sobi, INC | $227.90 | 2023-2024 | |
| Incyte Corporation | $225.61 | 2021-2025 | Niktimvo |
| Pfizer INC. | $209.06 | 2023-2024 | |
| Y-Mabs Therapeutics, INC. | $125.00 | 2024 | Danyelza |
| Celgene Corporation | $124.87 | 2021 | |
| Rigel Pharmaceuticals, INC. | $114.44 | 2025 | Tavalisse, Rezlidhia, Gavreto |
| Astrazeneca Pharmaceuticals LP | $113.46 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $105.36 | 2022 | |
| Genentech USA, INC. | $74.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.